Similar articles

• Topical vitamin D3 analogues: unapproved uses, dosages, or indications.

  Parish JL. Parish JL. Clin Dermatol. 2002 Sep-Oct;20(5):558-62. doi: 10.1016/s0738-081x(02)00269-9. Clin Dermatol. 2002. PMID: 12435526 Review. No abstract available.
• Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications.

  Wolf R, Matz H, Orion E, Tüzün B, Tüzün Y. Wolf R, et al. Clin Dermatol. 2002 Sep-Oct;20(5):531-46. doi: 10.1016/s0738-081x(02)00270-5. Clin Dermatol. 2002. PMID: 12435524 Review. No abstract available.
• Photodynamic therapy: unapproved uses, dosages, or indications.

  Salva KA. Salva KA. Clin Dermatol. 2002 Sep-Oct;20(5):571-81. doi: 10.1016/s0738-081x(02)00266-3. Clin Dermatol. 2002. PMID: 12435528 Review. No abstract available.
• Interferons: unapproved uses, dosages, or indications.

  Orion E, Matz H, Wolf R. Orion E, et al. Clin Dermatol. 2002 Sep-Oct;20(5):493-504. doi: 10.1016/s0738-081x(02)00274-2. Clin Dermatol. 2002. PMID: 12435520 Review. No abstract available.
• Psychotropic and neurotropic agents in dermatology: unapproved uses, dosages, or indications.

  Koo JY, Ng TC. Koo JY, et al. Clin Dermatol. 2002 Sep-Oct;20(5):582-94. doi: 10.1016/s0738-081x(02)00267-5. Clin Dermatol. 2002. PMID: 12435529 Review. No abstract available.